Skip to main content
TipRanks
Go Ultimate75% OFF

Stephen Isaacs Insider Profile

4 Followers

Stephen Isaacs, former President & CEO, Director at Chinook Therapeutics, holds 288.10K shares in Chinook Therapeutics (Ticker: KDNY). Most recently, Stephen Isaacs Sold 32,481 shares of Chinook Therapeutics on Sep 17, 2020 for an estimated value of $77.63K.

Stephen Isaacs's Trading History

KDNY
Chinook Therapeutics
Sep 17, 2020―Informative Sell77.63K$11.64M
KDNY
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Sep 17, 2020Informative Sell$77.63K32,481$2.39+0.30%
Dec 16, 2019Informative Sell$6.84K5,897$1.16-245.90%
Sep 17, 2019Informative Sell$40.43K31,098$1.30-93.00%
Dec 14, 2018Informative Sell$17.08K5,829$2.93+59.10%
Sep 14, 2018Informative Sell$156.69K24,143$6.49+80.80%

You May Also Like

Stephen Isaacs insider profile FAQ

What is the percentage of profitable transactions made by Stephen Isaacs?
The percentage of profitable transactions made by Stephen Isaacs is 50%.
What is the average return per transaction made by Stephen Isaacs?
The average return per transaction made by Stephen Isaacs is -33.20%.
What stocks does Stephen Isaacs hold?
Stephen Isaacs holds: KDNY stocks.
What was Stephen Isaacs’s latest transaction?
Stephen Isaacs’s latest transaction was an Informative Sell of $77.63K.
What was Stephen Isaacs's most profitable transaction?
Stephen Isaacs’s most profitable transaction was an Informative Sell of KDNY stock on September 14, 2018. The return on the trade was 80.80%.
What is Stephen Isaacs's role in Chinook Therapeutics?
Stephen Isaacs's role in Chinook Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.